NCT03404102

Brief Summary

The intrauterine device (IUD) is one of the most widely used reversible, long-term contraceptive methods in the world. But despite all its advantages; discontinuation rate of IUD ranged from 9.6% to 37.3 % (according to Demographic and Health Surveys data). In Egypt, in 2014, the discontinuation rate of IUD (within 12 months of use) was 14.3%.This study explores the differences around this rate in Egyptian university clinic and primary healthcare clinic with detailed percentages of possible causes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 17, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 12, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 19, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2018

Completed
Last Updated

January 19, 2018

Status Verified

January 1, 2018

Enrollment Period

8 months

First QC Date

January 12, 2018

Last Update Submit

January 12, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • measure discontinuation rate

    • To measure the discontinuation rate among copper IUD users in primary health care unit and university clinic.

    1 year

Secondary Outcomes (3)

  • exclude anemia

    1 year

  • comparison

    1 year

  • users" satisfaction

    1 year

Study Arms (2)

university clinic

* Enrollment: 200 Subjects will be enrolled from women attending family planning clinic for Cu- IUD insertion * Informed Consent: All participants will give their informed consent prior to enrollment. * Data collection \& recording: Data of each patient will be recorded in a Case Record Form (CRF). * Follow up visits /questionnaire: will be conducted from each subject at 6 months and 12 months after Cu-IUD insertion. User satisfaction score and haemoglobin serum level will be included in the questionnaire.

Device: Cu-IUD

primary healthcare unit clinic

* Enrollment: 200 Subjects will be enrolled from women attending family planning clinic for Cu- IUD insertion * Informed Consent: All participants will give their informed consent prior to enrollment. * Data collection \& recording: Data of each patient will be recorded in a Case Record Form (CRF). * Follow up visits /questionnaire: will be conducted from each subject at 6 months and 12 months after Cu-IUD insertion. User satisfaction score and haemoglobin serum level will be included in the questionnaire.

Device: Cu-IUD

Interventions

Cu-IUDDEVICE

Copper Intra-uterine device used as contraceptive method

primary healthcare unit clinicuniversity clinic

Eligibility Criteria

Age18 Years - 49 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

women attending family planning for Cu- IUD insertion who meet inclusion criteria

You may qualify if:

  • \. Age from 18-49 years. 2. Women planning for Cu-IUD insertion as a contraceptive method.

You may not qualify if:

  • \. Any woman with condition included in Category 3 or 4 for Cu-IUD in medical eligibility criteria for contraceptive use (MEC) -World Health Organization-2015.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams Maternity hospital

Cairo, Ain Shams, 11566, Egypt

RECRUITING

Study Officials

  • Ain Shams Maternity Hospital

    Ain Shams Maternity Hospital

    STUDY DIRECTOR

Central Study Contacts

noha elzaydy, M.B.B.Ch.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
researcher

Study Record Dates

First Submitted

January 12, 2018

First Posted

January 19, 2018

Study Start

October 17, 2017

Primary Completion

June 1, 2018

Study Completion

September 1, 2018

Last Updated

January 19, 2018

Record last verified: 2018-01

Locations